Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Acute Tubular Necrosis from Contrast-Induced Nephropathy

Clinical Presentation and Diagnosis

  • Contrast-induced AKI typically manifests within 24-48 hours (up to 2-5 days) after contrast administration, which precisely matches this patient's presentation 1, 2
  • The American Journal of Kidney Diseases suggests that pre-renal azotemia is unlikely because the patient's vital signs are stable without evidence of volume depletion 1
  • Acute interstitial nephritis is less likely because it typically develops over days to weeks after drug exposure, not within 48 hours 3
  • Acute glomerular nephritis is unlikely because the temporal relationship strongly suggests contrast toxicity rather than glomerular disease 1, 2, 3

Risk Factors and Prevention

  • Advanced age is a recognized risk factor for contrast-induced nephropathy, as stated by the American Journal of Kidney Diseases 1, 2
  • Pre-existing renal impairment is the most critical risk factor for developing contrast-induced AKI, according to the American Journal of Kidney Diseases 1, 2
  • Elderly patients have higher baseline risk even without documented prior renal dysfunction, as noted by the American Journal of Kidney Diseases 1

Clinical Significance and Outcome

  • In cancer patients with pre-existing kidney disease, 50% of contrast-induced nephropathy cases result in irreversible renal damage, as reported in Kidney International 3
  • The American College of Cardiology is not mentioned in this article, however, the Kidney International journal reports that contrast-induced nephropathy is associated with increased morbidity and in-hospital mortality 3